DNA Methylation-Mediated Overexpression of CXCL1 in Helicobacter pylori-Induced Gastric Cancer: In Silico- and In Vitro-Based Identification of a Potential Biomarker for Carcinogenesis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24010795 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jibran Sualeh Muhammad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Hussein Cancer Center, Research Institute for Medical and Health Sciences, University of Sharjah, King Hussein Cancer Foundation.
Abstract (Originalsprache)
Given the high global prevalence and mortality associated with gastric cancer, and its known causal link with Helicobacter pylori infection, it is important to have a biomarker to identify malignant transformation at early stages. Previously, we, and others, have reported that H. pylori-induced epigenetic changes could mediate carcinogenic transformation of the gastric cells. Also, CXCL1 secreted by gastric cancer cells was reported as a key diagnostic and prognostic biomarker for the pathogenic progression of gastric cancer. In this study, for the first time, we aimed to investigate the role of H. pylori-induced DNA methylation-based epigenetic regulation of CXCL1. In silico analysis of publicly available datasets and in vitro experiments were performed. Our results showed that CXCL1 is highly expressed in both gastric cancer tissues and gastric cancer cells infected with H. pylori. Further, we showed and confirmed that H. pylori-mediated overexpression of CXCL1 is due to hypomethylation of its promoter region. Since epigenetic events such as DNA methylation happen early in the sequence; H. pylori-induced CXCL1 hypomethylation could likely be detected at an early stage of gastric cancer development. Epigenetic modifications, such as CXCL1 hypomethylation, are reversible and could potentially be a therapeutic target using demethylation drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.
- Department of Environmental Health, University of Fukui School of Medical Sciences, Fukui 910-1193, Japan.
- Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates.
ORCID-Profile: Jibran Sualeh Muhammad, Ghalia Khoder
Förderung
- King Hussein Cancer Center
- Research Institute for Medical and Health Sciences, University of Sharjah
- King Hussein Cancer Foundation
- Jordan
- Research Institute for Medical and Health Sciences
- University of Sharjah
- J.S.M.
- G.K.
Zitieren
APA
Muhammad, J. S., Manzoor, S., Cui, Z. G., & Khoder, G. (2023). DNA Methylation-Mediated Overexpression of CXCL1 in Helicobacter pylori-Induced Gastric Cancer: In Silico- and In Vitro-Based Identification of a Potential Biomarker for Carcinogenesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24010795
Vancouver
Muhammad JS, Manzoor S, Cui ZG, Khoder G. DNA Methylation-Mediated Overexpression of CXCL1 in Helicobacter pylori-Induced Gastric Cancer: In Silico- and In Vitro-Based Identification of a Potential Biomarker for Carcinogenesis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24010795
BibTeX
@article{Muhammad2023,
author = {Muhammad, Jibran Sualeh and Manzoor, Shaista and Cui, Zheng-Guo and Khoder, Ghalia},
title = {DNA Methylation-Mediated Overexpression of CXCL1 in Helicobacter pylori-Induced Gastric Cancer: In Silico- and In Vitro-Based Identification of a Potential Biomarker for Carcinogenesis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24010795}
}
EUVIMED